Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-07

Clinical Trial Update: Physiological Effects of Nebulized Salbutamol in Acute Respiratory Failure Patients on HFNC [Phase 2, Phase 3]

View source ↗

Summary

Update on a Phase 2/3 trial evaluating the physiological effects of nebulized salbutamol in acute respiratory failure patients on high-flow nasal cannula; the s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebulized salbutamol (salbutamol)

Snippet

Sponsor: Università degli Studi di Ferrara | Conditions: Acute Respiratory Failure, Pneumonia | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING